Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Rethinking pharmaceutical pain management beyond opioids – the pharmaphorum podcast

AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo

The post-Covid New Normal: a golden opportunity for the NHS?

NHS England trials first medicine deliveries by drone

Astellas teams up with UK biotech Mogrify on hearing loss project

von Willebrand disease

NHS

Market Access/ News/ News

Takeda’s bleeding disorder drug Veyvondi backed for NHS use

Phil Taylor Haematology, NHS England, Takeda, Veyvondi, von Willebrand disease 0 Comment

NHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it

X

Takeda’s bleeding disorder drug Veyvondi backed for NHS use

https://pharmaphorum.com/news/takedas-bleeding-disorder-drug-veyvondi-backed-for-nhs-use/

Shire HQ

Shire’s von Willebrand disease therapy Veyvondi approved in EU

Richard Staines Shire, von Willebrand disease 0 Comment

The European Commission has approved Shire’s Veyvondi for treatment of the bleeding disorder von Willebrand disease (VWD). VWD

X

Shire’s von Willebrand disease therapy Veyvondi approved in EU

https://pharmaphorum.com/news/shires-von-willebrand-disease-therapy-veyvondi-approved-in-eu/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Partners come on board GSK's plan for Stevenage life science hub
Teva poaches Vertex exec as new head of R&D
AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo
After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome
Astellas teams up with UK biotech Mogrify on hearing loss project

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com